Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Medexus Pharmaceuticals
Medexus Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ixinity
Coagulation factor ix recombinant human
2015-04-29
—
Rasuvo
Methotrexate
2014-07-10
2026-2033
Leukemia
,
Juvenile arthritis
,
Psoriatic arthritis
,
Breast neoplasms
,
Psoriasis
,
Stomach neoplasms
,
Esophageal neoplasms
,
Rheumatoid arthritis
,
Lung neoplasms
,
Crohn disease
,
Precursor cell lymphoblastic leukemia-lymphoma
,
Hydatidiform mole
,
Osteosarcoma
,
Arthritis
,
Mycosis fungoides
,
Testicular neoplasms
,
Choriocarcinoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Treosulfan
myelodysplastic syndromes
,
myeloid leukemia acute
Coagulation factor ix recombinant human
hemophilia a
,
hematologic diseases
,
hemophilia b
Trenonacog alfa
hemophilia b
,
hemophilia a
Nadide
neoplasms
,
breast neoplasms
,
non-hodgkin lymphoma
,
colorectal neoplasms
Apvo101
hemophilia a
,
hemophilia b
Demand
chronic urticaria
,
urticaria
,
sickle cell anemia
,
arthritis
,
gouty arthritis
,
gout
,
macular degeneration
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use